|
There was an allegation of questionable elecsys insulin results for 6 patient samples on a cobas 8000 - cobas e 602 module.The customer questioned the low initial results which prompted them to repeat the patient samples.On (b)(6) 2024, sample 1 had an initial insulin result of 16.66 uu/ml.The sample was repeated on another e602 analyzer and the result was 21.1 uu/ml.On (b)(6) 2024, sample 2 had an initial insulin result of 7.10 uu/ml.The sample was repeated on another e602 analyzer and the result was 14.1 uu/ml.On (b)(6) 2024, the sample was repeated on the initial e602 analyzer and the result was 14.88 uu/ml.On (b)(6) 2024, sample 3 had an initial insulin result of 17.25 uu/ml.The sample was repeated on another e602 analyzer and the result was 35 uu/ml.On (b)(6) 2024, the sample was repeated on the initial e602 analyzer and the result was 35.23 uu/ml.On (b)(6) 2024, sample 4 had an initial insulin result of 3.21 uu/ml.The sample was repeated on another e602 analyzer and the result was 11.9 uu/ml.On (b)(6) 2024, the sample was repeated on the initial e602 analyzer and the result was 11.18 uu/ml.On (b)(6) 2024, sample 5 had an initial insulin result of 6.90 uu/ml.The sample was repeated on another e602 analyzer and the result was 15.7 uu/ml.On (b)(6) 2024, the sample was repeated on the initial e602 analyzer and the result was 15.08 uu/ml.On (b)(6) 2024, sample 6 had an initial insulin result of 3.16 uu/ml.The sample was repeated on another e602 analyzer and the result was 19.9 uu/ml.On (b)(6) 2024, the sample was repeated on the initial e602 analyzer and the result was 20.62 uu/ml.
|